This Obesity Drug Stock Surges 60% on Phase 3 News
A notable fund sold millions of dollars’ worth of shares as this obesity drug stock jumped on Phase 3 momentum. Here’...
This guide identifies key asset categories to hold in a new crypto portfolio, with beginner friendly risk considerations.
27,914 articlesA notable fund sold millions of dollars’ worth of shares as this obesity drug stock jumped on Phase 3 momentum. Here’...
A new breed of daily-reset covered-call ETFs aims to preserve more upside while delivering monthly income. Here’s how...
Microsoft is doubling down on AI. This article lays out scenarios, risks, and concrete steps to understand where will...
SentinelOne stock sinking today has investors weighing earnings quality against growth potential. This article breaks...
ServiceNow could deliver durable growth as organizations automate more workflows. This article lays out the bull case...
Micron Technology races higher on AI memory demand and supply tightness. This piece outlines why investors may consid...
Could Palantir move higher over the next year? This guide breaks down three realistic scenarios, key catalysts, and p...
NVIDIA just revealed owns a notable minority stake in Nebius, triggering a sharp stock move. This article breaks down...
Rigetti Computing lives at the edge of technology and finance. This article breaks down the revenue puzzle, the risks...
Investors are watching Apple’s latest Siri reveal to see if it marks a meaningful AI leap or just another upgrade. Th...
Nvidia is moving beyond chips into AI agents, changing how businesses deploy AI and how investors should value the co...
IonQ stock ended this week in the green after an early dip. Here’s what moved the quantum-computing name and how regu...